Search for: "ABBOTT v. ABBOTT"
Results 2261 - 2280
of 2,570
Sorted by Relevance
|
Sort by Date
4 Jun 2018, 3:04 pm
" Flynt v. [read post]
17 Sep 2010, 9:15 am
Patent No. 6,703,403 owned by Abbott Laboratories and entitled METHOD FOR IMPROVING PHARMACOKINETICS. [read post]
16 May 2008, 8:03 am
: (GenericsWeb), Europe: New EBA referral T 1319/04 regarding patentability of known medicament for new treatment of same illness: (IPKat), Europe: Patentability of biotechnology in Europe: (IAM), Europe: New EPO Enlarged Board case referrals: T1319/04 Dosage Regimen, T1242/06 Essential Biological Process: (Hal Wegner), Thailand: Compulsory licensing: Affordable health for Thailand thanks to Matrix Labs: (Spicy IP), Thailand: European Parliament set to reprimand Mandelson for… [read post]
13 May 2010, 12:27 pm
Abbott Laboratories, 2009 WL 2231701 (S.D.N.Y. [read post]
15 Jan 2008, 3:06 am
filed 03/22/07 1:07-cv-01721 Abbott Laboratories et al v. [read post]
15 Dec 2010, 2:17 am
General Coming soon: International Classification of traditional medicine by WHO (Spicy IP) Teva Pharma uses online game to promote generic substitution (Patent Baristas) Australia: APO: Success of phase 3 trials ‘obvious’ in view of phase 1 and 2: Genentec, Inc (Patentology) Brazil: Government support to impel Brazil generic market (GenericsWeb) EU: EPO Enlarged Board of Appeal decides Broccoli (G2/07) and Tomatoes (G1/08) – essentially biological breeding processes not patentable… [read post]
12 Mar 2020, 10:24 am
Abbott Labs. [read post]
18 Sep 2022, 4:19 am
United States v. [read post]
21 Apr 2023, 8:16 am
And in West Virginia v. [read post]
13 Dec 2016, 4:00 am
Wise v Abbott Laboratories, Limited, 2016 ONSC 7275 (CanLII) This case raises the issue – NOT THE PROBLEM – of keeping current with the spate of decisions constantly being released, even in one’s own jurisdiction, of arguably relevant decisions that are released between the time argument ends and the reasons in the lawyers’ own case are released. [read post]
11 Nov 2009, 4:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: EU: Generics producers: Criminal sanctions can stop counterfeit drugs (IP Watch) Prandin (Repaglinide) – US: Federal Circuit grants stay of preliminary relief pending full appellate review: Novo Nordisk v Caraco (Patently-O) General Eduardo Pisani of Bristol-Myers Squibb is the new IFPMA Director General (IP… [read post]
17 Oct 2011, 5:58 am
Abbott Laboratories, No. 11-C-4860 (N.D. [read post]
6 Jul 2007, 4:29 am
See Larkin v. [read post]
11 Nov 2009, 6:05 am
Abbott, 574 F.3d 203, 206 (3d Cir. 2009) (“As in all cases of statutory interpretation, our inquiry begins with the language of the statute and focuses on Congress' intent. [read post]
15 Nov 2023, 1:28 pm
Two cases, Becerra v. [read post]
5 May 2010, 10:14 pm
Abbott Labs., 512 F.3d 1363, 1378 (Fed. [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its… [read post]
3 Sep 2015, 6:36 am
Health Ctr. v. [read post]
22 Jul 2015, 9:03 am
Cariou v. [read post]
11 Aug 2022, 5:49 pm
It’s not about balancing incommensurable property v. speech, but speech v. speech which is more feasible. [read post]
